Welcome To the Stock Synergy, Momentum & Breakout HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: cgix new coverage...already had a big run so be careful

Cancer Genetics Inc (NASDAQ:CGIX) is now covered by analysts at Aegis. They set a "buy" rating and a $25.00 price target on the stock. 80.4% Upside

Share
New Message
Please login to post a reply